Sandoz acquires AmLactin therapeutic skin care brand

AmLactin- a therapeutic skin care brand based in the US has been acquired by Sandoz - a pharmaceutical company.

AmLactin’s range includes products for skin based on alpha hydroxy therapy. Formulas contain three times the concentration of AHA lactic acid compared with other top selling therapeutic moisturisers, according to the brand, with products include: Foot Repair, Ultra Smoothing, Rapid Relief and Daily Moisturizing Body Lotion.

Sandoz aims to continue delivering high value, high quality generics and novel therapies to customers with “even greater precision”.


Related Articles